Company profile: Avenacy
1.1 - Company Overview
Company description
- Provider of critical injectable pharmaceuticals, manufacturing generic and therapeutic equivalents including eptifibatide (generic Integrilin) for acute coronary syndrome, bivalirudin (generic Angiomax), fosaprepitant, fulvestrant in prefilled syringe kits, and desmopressin acetate, offered in sterile single-dose vials, multi-dose vials, and sterile powder formulations.
Products and services
- Eptifibatide for Injection: A critical injectable generic equivalent for Integrilin, used in acute coronary syndrome, supplied as a sterile single-dose vial
- Fulvestrant Injection: A critical injectable medication offered in a prefilled syringe kit, used for specific medical treatments
- Bivalirudin for Injection: A generic equivalent for Angiomax, used in specific medical treatments, available as a sterile powder
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avenacy
Lucy Scientific
HQ: Canada
Website
- Description: Provider of research, development, and manufacturing of controlled psychotropic drugs, offering targeted formulations, single molecule fractions, crude extracts, raw materials, and white- and private-label products to support mental research and the creation of psychotropic and psychedelic therapeutics across organic, synthetic, and biosynthetic categories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lucy Scientific company profile →
Prime Global
HQ: United States
Website
- Description: Provider of medical communications services via a group of seven full-service medical communications agencies and two specialist consultancies, with a people-first focus on creative, innovative science communication.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prime Global company profile →
Labcorp Drug Development
HQ: United States
Website
- Description: Provider of global contract research and drug development services, delivering early- and late-stage support including drug discovery studies, preclinical and clinical pharmacology, clinical trial execution with patient recruitment and data analysis, biomarker services, oncology research (cell line assays, tumor models), biopharma laboratory services with antibody-drug conjugate capabilities, and cell and gene therapy development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labcorp Drug Development company profile →
Exela Pharma Sciences
HQ: United States
Website
- Description: Provider of sterile injectable pharmaceuticals for the healthcare sector, offering Sodium Bicarbonate Injection (electrolyte replenisher/systemic alkalizer), Caffeine Citrate Injection, ELCYS (cysteine hydrochloride injection), GLYRX-PF (synthetic anticholinergic), Nipride RTU (sodium nitroprusside), and Caffeine Citrate Oral Solution.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Exela Pharma Sciences company profile →
Siegfried
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing for active pharmaceutical ingredients and drug products, including intermediates and controlled substances. Services span process development and optimization, formulation and pilot-scale production, registration support, and packaging and logistics for tablets, capsules, sterile vials, ampoules, cartridges, and ointments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Siegfried company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avenacy
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avenacy
2.2 - Growth funds investing in similar companies to Avenacy
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avenacy
4.2 - Public trading comparable groups for Avenacy
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →